Skip to main content
Premium Trial:

Request an Annual Quote

RXi Inks Ocular Disease Collaboration with UMMS

Premium

RXi Pharmaceuticals said this week that it has formed a collaboration with the University of Massachusetts Medical School's Shalesh Kaushal to develop the company's self-delivering RNAi molecules as therapeutics for ocular diseases.

Conditions that will be a focus of the deal include age-related macular degeneration, RXi said.

Specific terms of the arrangement were not disclosed.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.